Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Piguet

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Applied Microbiology|August 1, 1970
New method for detecting bacteriocin productionD A Kékessy, J D Piguet
Schweizerische Medizinische Wochenschrift|April 18, 1981
[Clinical suspicion of tuberculosis and non-tuberculous mycobacteria]G Kuonen, R de Haller, J D Piguet
Immunology|December 1, 1971
Molecular weight estimation of immunoglobulin subunits of polyacrylamide gelC Ahmad-Zadeh, J D Piguet, L Colli
Revue Medicale De La Suisse Romande|November 1, 1993
[Secondary polycythemias: the role of erythropoietin]R Rognon, D Piguet, M Mégevand, et al.
Schweizerische Medizinische Wochenschrift|January 10, 1987
[Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]D Piguet, P M Schmidt, F Delacrétaz, et al.
Cancer Genetics and Cytogenetics|November 1, 1986
Ring chromosomes and hematologic disordersC Werner-Favre, P Beris, D Piguet, et al.
Schweizerische Medizinische Wochenschrift|January 22, 1983
[Non-tuberculous Mycobacteria: epidemiologic importance and current pathogenicity]R De Haller, J D Piguet, J De Haller
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|July 9, 1998
[A rare complication of permanent venous access: constriction, fracture and embolization of the catheter]Y Groebli, P Wuthrich, P Tschantz, et al.
American Journal of Clinical Pathology|February 1, 1987
Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsyF Delacrétaz, P M Schmidt, D Piguet, et al.
Clinical and Experimental Immunology|February 5, 2008
Redimune NF Liquid, a ready-to-use, high-concentration intravenous immunoglobulin therapy preparation, is safe and typically well tolerated in the routine clinical management of a broad range of conditionsD Piguet, C Tosi, J-M Lüthi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Applied Microbiology|August 1, 1970
New method for detecting bacteriocin productionD A Kékessy, J D Piguet
Schweizerische Medizinische Wochenschrift|April 18, 1981
[Clinical suspicion of tuberculosis and non-tuberculous mycobacteria]G Kuonen, R de Haller, J D Piguet
Immunology|December 1, 1971
Molecular weight estimation of immunoglobulin subunits of polyacrylamide gelC Ahmad-Zadeh, J D Piguet, L Colli
Revue Medicale De La Suisse Romande|November 1, 1993
[Secondary polycythemias: the role of erythropoietin]R Rognon, D Piguet, M Mégevand, et al.
Schweizerische Medizinische Wochenschrift|January 10, 1987
[Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]D Piguet, P M Schmidt, F Delacrétaz, et al.
Cancer Genetics and Cytogenetics|November 1, 1986
Ring chromosomes and hematologic disordersC Werner-Favre, P Beris, D Piguet, et al.
Schweizerische Medizinische Wochenschrift|January 22, 1983
[Non-tuberculous Mycobacteria: epidemiologic importance and current pathogenicity]R De Haller, J D Piguet, J De Haller
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|July 9, 1998
[A rare complication of permanent venous access: constriction, fracture and embolization of the catheter]Y Groebli, P Wuthrich, P Tschantz, et al.
American Journal of Clinical Pathology|February 1, 1987
Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsyF Delacrétaz, P M Schmidt, D Piguet, et al.
Clinical and Experimental Immunology|February 5, 2008
Redimune NF Liquid, a ready-to-use, high-concentration intravenous immunoglobulin therapy preparation, is safe and typically well tolerated in the routine clinical management of a broad range of conditionsD Piguet, C Tosi, J-M Lüthi, et al.
Pageof 4